Intervention Review

Metrifonate for Alzheimer's disease

  1. Jess López-Arrieta1,*,
  2. Lon Schneider2

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 19 APR 2006

Assessed as up-to-date: 28 FEB 2008

DOI: 10.1002/14651858.CD003155.pub3


How to Cite

López-Arrieta J, Schneider L. Metrifonate for Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD003155. DOI: 10.1002/14651858.CD003155.pub3.

Author Information

  1. 1

    Hospital Universitario La Paz-Cantoblanco, Geriatric Department, Madrid, Spain

  2. 2

    University of Southern California Keck School of Medicine, Los Angeles, CA, USA

*Jess López-Arrieta, Geriatric Department, Hospital Universitario La Paz-Cantoblanco, Ctra de Colmenar km 14,500, Madrid, 28049, Spain. pdarrieta@wanadoo.es. jlopezar.hgugm@salud.madrid.org.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 19 APR 2006

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.